Effect of CYP2C19, UGT1A8, and UGT2B7 on valproic acid clearance in children with epilepsy: a population pharmacokinetic model

被引：0
|
作者：
Shenghui Mei
Weixing Feng
Leting Zhu
Xingang Li
Yazhen Yu
Weili Yang
Baoqin Gao
Xiaojuan Wu
Fang Fang
Zhigang Zhao
机构：
[1] Capital Medical University,Department of Pharmacy, Beijing Tiantan Hospital
[2] Capital Medical University,Department of Clinical Pharmacology, College of Pharmaceutical Sciences
[3] Capital Medical University,Department of Neurology, Beijing Children’s Hospital
[4] Capital Medical University,Department of Pediatrics, Beijing Tiantan Hospital
来源：
European Journal of Clinical Pharmacology | 2018年 / 74卷
关键词：
Valproic acid; Uridine diphosphate glucuronosyltransferase; Cytochrome P450 family 2 subfamily C member 19; Clearance; Children; Population pharmacokinetic model; Nonlinear mixed-effects modeling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1029 / 1036
页数：7
相关论文
共 50 条
  • [21] Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis
    Wang, Ping
    Lin, Xiao-Qian
    Cai, Wen-Ke
    Xu, Gui-Li
    Zhou, Meng-Di
    Yang, Mei
    He, Gong-Hao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (04) : 433 - 442
  • [22] Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury
    Yu, Mengchen
    Zhao, Yan
    Zhou, Fan
    Li, Weiliang
    Liu, Jing
    Zhao, Linlin
    Song, Zhirui
    Tong, Ling
    Zhang, Ying
    Wang, Yajuan
    Shang, Shenglan
    Yu, Airong
    PHARMACOGENOMICS, 2024, 25 (12-13) : 527 - 538
  • [23] Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects
    Chung, J-Y
    Cho, J-Y
    Yu, K-S
    Kim, J-R
    Lim, K. S.
    Sohn, D-R
    Shin, S-G
    Jang, I-J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (04) : 595 - 600
  • [24] Correlations between UGT2B7*2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients
    Zhang, Hui
    Zhang, Wenfang
    Li, Yuechun
    Yan, Jie
    Zhang, Jinfeng
    Wang, Baojun
    BRAIN & DEVELOPMENT, 2018, 40 (02): : 100 - 106
  • [25] A POPULATION PHARMACOKINETIC ANALYSIS OF ESCITALOPRAM AND THE EFFECT OF CYP2C19 ON CLEARANCE IN CHILDREN AND ADOLESCENTS
    Poweleit, E.
    Mizuno, T.
    Taylor, Z.
    Vaughn, S.
    Desta, Z.
    Strawn, J.
    Ramsey, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S25 - S25
  • [26] Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone
    Thibaudeau, J
    Lépine, J
    Tojcic, J
    Duguay, Y
    Pelletier, G
    Plante, M
    Brisson, J
    Têtu, B
    Jacob, S
    Perusse, L
    Bélanger, A
    Guillemette, C
    CANCER RESEARCH, 2006, 66 (01) : 125 - 133
  • [27] Tramadol-related fatalities: Metabolic ratios & SNPs/INDELs belonging to UGT1A8, UGT2B7, ABCC2, and SLC22A1
    Aly, Sanaa M.
    Sabaouni, Naoual
    Hennart, Benjamin
    Gaulier, Jean-michel
    Allorge, Delphine
    FORENSIC SCIENCE INTERNATIONAL-GENETICS, 2025, 76
  • [28] The Influence of UGT2B7, UGT1A8, MDR1, ALDH, ADH, CYP3A4 and CYP3A5 Genetic Polymorphisms on the Pharmacokinetics of Silodosin in Healthy Chinese Volunteers
    Wang, Zining
    Xiang, Qian
    Cui, Yimin
    Zhao, Xia
    Zhou, Ying
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (03) : 239 - 243
  • [29] EFFECT OF UGT1A4 AND UGT2B7 POLYMORPHISM ON LAMOTRIGINE METABOLISM DURING PREGNANCY
    Petrenaite, V
    Ohman, I
    Ekstrom, L.
    Bertilsson, L.
    Saebye, D.
    Tomson, T.
    Sabers, A.
    EPILEPSIA, 2016, 57 : 68 - 68
  • [30] Effect of UGT1A4 and UGT2B7 polymorphism on lamotrigine metabolism during pregnancy
    Petrenaite, V.
    Ohman, I.
    Ekstrom, L.
    Bertilsson, L.
    Saebye, D.
    Tomson, T.
    Sabers, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 504 - 504
12345